Registered entities
DICERNA PHARMACEUTICALS INC
Reg. No. 1399529United States
Innovation
110 patent families (47 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace slowing. Cited 9,047 times.
| Year | Filings |
|---|---|
| 2015 | 18 |
| 2016 | 17 |
| 2017 | 22 |
| 2018 | 19 |
| 2019 | 24 |
| 2020 | 31 |
| 2021 | 35 |
| 2022 | 48 |
| 2023 | 61 |
| 2024 | 43 |
| 2025 | 23 |
| 2026 | 4 |
Investor mix
20 investors on record; lead investors include RA Capital Management, Domain Associates; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 60% |
| Private equity | 2 | 10% |
| Bank & private debt | 3 | 15% |
| Other / undisclosed | 3 | 15% |